Despite clinical trial data showing inferior vena cava (IVC) filters are ineffective for reducing mortality following deep vein thrombosis (DVT), as well as guideline recommendations against their use ...

More than one-third of patients undergoing catheter-directed thrombolysis of deep vein thrombosis receive an inferior vena cava (IVC) filter, yet placement of the device is not associated with a ...

AUSTIN, Texas -- Inferior vena cava (IVC) filters had mixed results against cancer-related venous thromboembolism (VTE) in studies presented here. In a population-based analysis of more than 90,000 ...

The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...

Thrombophilic patients undergoing elective neurosurgery who receive a temporary inferior vena cava (IVC) filter show dramatically fewer thrombotic or hemorrhagic complications compared with ...

Humana Inc. today announced research findings that suggest inferior vena cava (IVC) filters may be overused in managed care populations, and that filters may not always be removed after they are no ...

Deep vein thrombosis is a medical condition in which blood clots develop in the deep veins of the body, often in the legs, thigh or pelvis. These clots can break loose and travel to the lungs and can ...

Please provide your email address to receive an email when new articles are posted on . Prophylactic inferior vena cava filter placement declined in the United States from 2005 to 2014, but rates ...

Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...